Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
Literal federal measure citations: H.R. 1
2025 · 3rd Quarter (July 1 - Sep 30)
THE HEMOPHILIA ALLIANCE
Filed by ARTEMIS POLICY GROUP LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- ARTEMIS POLICY GROUP LLC
- Client
- THE HEMOPHILIA ALLIANCE
- Filing UUID
- f4d2f6b8-e187-432b-b9be-5511b6033990
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Literal federal measure citations: H.R. 1, HR 864, HR 247, HR 1, HR 5371, S 46
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Literal federal measure citations: HR 5256
Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.